The abstract is read at the publisher; the summary is JClub's.
About ~20% of mismatch repair–proficient colorectal cancer (CRC) tumors show T cell infiltration levels comparable to dMMR tumors despite lacking specific somatic driver mutations or higher tumor mutational burden.
- Why it matters: Tumor immune engagement can refine CRC subtyping beyond mismatch repair status, but it was unclear whether any pMMR tumors also contain tumor-engaged T cells.
- What they did: The study integrated spatial profiling with genomic analysis to identify T cell–infiltrated pMMR tumors and characterize their T cell phenotypes, including PD1+ Granzyme B+ CD8+ cells and TCF1+ precursor exhausted T cells.
- The result: tipMMR tumors occur at similar frequency to dMMR tumors and display an immunologically active state, suggesting immunotherapy should be considered for this pMMR subgroup.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.